News & Articles

In a Phase 3 trial, the vaccine was 100% effective and generally well tolerated in participants aged 12 to 15 years

Discover how collaborative research between big pharma and academia is using the latest proteomics platforms to revolutionize drug discovery

KSQ Therapeutics uses technology created at MIT to study the role of every human gene in disease biology

New, reversible CRISPR method can control gene expression while leaving underlying DNA sequence unchanged

Vaccine, trialed in 450 children, shows favorable safety profile and was well-tolerated

COVID-19 infections fell by 65% percent after a first dose of the Oxford-AstraZeneca or Pfizer-BioNTech vaccines in this large community surveillance study

A new Prenetics Innovation Technology Centre will be established for advanced molecular diagnostics

Anti-cancer drug delivery to target tumor sites now becomes more effective with novel multi-stimuli-responsive drug delivery systems

An insider’s view on leveraging the latest single-cell technologies, including cell sorting and single-cell sequencing, to understand what drives response or resistance in checkpoint therapies

Dr. Tania Nolan outlines how her team is designing assays to identify new variants and why these are critical to managing the global response

Each line of ValuPanel Reagents consists of separately delivered probes and primers, which allow assay flexibility and sizes that can help facilitate scale-up

AI could hold the key to more targeted treatment, according to new research

Watch world-leading scientists online, May 11-12, to discover the latest tools and techniques advancing COVID-19 research, immunotherapy development, drug screening, cancer diagnostics and more

Discover how a brain organoid core facility is applying its glioblastoma model towards developing patient mini-brains

In a ten-year project, a team from the Karl Landsteiner University of Health Sciences has identified a previously unknown role of calcium channels in the formation of synaptic connections

Catch up on this on-demand webinar and register for part 2 to learn everything you need to know to get ready for IVDR

Potent antibodies shown to retain binding to major COVID-19-causing “South African” variant